Adverum Biotechnologies to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day – Nasdaq
|
Adverum Biotechnologies to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day
Nasdaq MENLO PARK, Calif., April 06, 2017 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a leading gene therapy company advancing novel medicines to address unmet needs in serious rare and ocular diseases, announced today that … |
